Analysis of textbook outcomes for ampullary carcinoma patients following pancreaticoduodenectomy

被引:2
|
作者
Zhang, Xiao-Jie [1 ]
Fei, He [1 ]
Guo, Chun-Guang [1 ]
Sun, Chong-Yuan [1 ]
Li, Ze-Feng [1 ]
Li, Zheng [1 ]
Chen, Ying-Tai [1 ]
Che, Xu [1 ,2 ,3 ]
Zhao, Dong-Bing [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Pancreat & Gastr Surg Oncol, Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Radiat Oncol,Canc Hosp, Shenzhen 518116, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen 518116, Peoples R China
来源
关键词
Ampullary carcinoma; Textbook outcomes; Pancreaticoduodenectomy; Prognosis; LONG-TERM SURVIVAL; CANCER; QUALITY; RISK; ASSOCIATION; MANAGEMENT; MORTALITY; RESECTION; MEDICARE; SURGERY;
D O I
10.4240/wjgs.v15.i10.2259
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Textbook outcomes (TOs) have been used to assess the quality of surgical treatment for many digestive tumours but not ampullary carcinoma (AC).AIM To discuss the factors associated with achieving a TO and further explore the prognostic value of a TO for AC patients undergoing curative pancreaticoduodenectomy (PD).METHODS Patients who underwent PD at the China National Cancer Center between 1998 and 2020 were identified. A TO was defined by R0 resection, examination of >= 12 Lymph nodes, no prolonged hospitalization, no intensive care unit treatment, no postoperative complications, and no 30-day readmission or mortality. Cox regression analysis was used to identify the prognostic value of a TO for overall survival (OS) and recurrence-free survival (RFS). Logistic regression was used to identify predictors of a TO. The rate of a TO and of each indicator were compared in patients who underwent surgery before and after 2010.RESULTS Ultimately, only 24.3% of 272 AC patients achieved a TO. A TO was independently associated with improved OS [hazard ratio (HR): 0.443, 95% confidence interval (95%CI): 0.276-0.711, P = 0.001] and RFS (HR: 0.379, 95%CI: 0.228-0.629, P < 0.001) in the Cox regression analysis. Factors independently associated with a TO included a year of surgery between 2010 and 2020 (OR: 4.549, 95%CI: 2.064-10.028, P < 0.001) and N1 stage disease (OR: 2.251, 95%CI: 1.023-4.954, P = 0.044). In addition, the TO rate was significantly higher in patients who underwent surgery after 2010 (P < 0.001) than in those who underwent surgery before 2010.CONCLUSION Only approximately a quarter (24.3%) of AC patients achieved a TO following PD. A TO was independently related to favourable oncological outcomes in AC and should be considered as an outcome measure for the quality of surgery. Further multicentre research is warranted to better elucidate its impact.
引用
收藏
页码:2259 / 2271
页数:13
相关论文
共 50 条
  • [31] Outcomes of endoscopic papillectomy in elderly patients with ampullary adenoma or early carcinoma
    Nguyen, N.
    Shah, J. N.
    Binmoeller, K. F.
    ENDOSCOPY, 2010, 42 (11) : 975 - 977
  • [32] Clinical outcomes and molecular characteristics of patients with locoregional ampullary carcinoma.
    Eslinger, Cody
    Chang, Isabela
    Fonseca, Rodrigo
    Sahvan, Oudai
    Yee, Claire I.
    Truman, Mia
    Mcwilliams, Robert R.
    Babiker, Hani M.
    Pai, Rish
    Wu, Christina
    Ahn, Daniel H.
    Borad, Mitesh
    Bekaii-Saab, Tanios S.
    Sonbol, Mohamad B.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 732 - 732
  • [33] The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
    Showalter, Timothy N.
    Zhan, Tingting
    Anne, P. Rani
    Chervoneva, Inna
    Mitchell, Edith P.
    Yeo, Charles J.
    Rosato, Ernest L.
    Kennedy, Eugene P.
    Berger, Adam C.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (08) : 1411 - 1416
  • [34] The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
    Timothy N. Showalter
    Tingting Zhan
    P. Rani Anne
    Inna Chervoneva
    Edith P. Mitchell
    Charles J. Yeo
    Ernest L. Rosato
    Eugene P. Kennedy
    Adam C. Berger
    Journal of Gastrointestinal Surgery, 2011, 15 : 1411 - 1416
  • [35] Predictors of Survival in Ampullary, Bile Duct and Duodenal Cancers Following Pancreaticoduodenectomy: a 10-Year Multicentre Analysis
    Stéphane Bourgouin
    Jacques Ewald
    Julien Mancini
    Vincent Moutardier
    Jean-Robert Delpero
    Yves-Patrice Le Treut
    Journal of Gastrointestinal Surgery, 2015, 19 : 1247 - 1255
  • [36] Textbook outcomes after pancreaticoduodenectomy in high risk patients: results from a high volume UK centre
    Raza, Syed Soulat
    Nutu, Anisa
    Powell-Brett, Sarah
    Chatzizacharias, Nikolaos
    Dasari, Bobby
    Isaac, John
    Abradelo, Manuel
    Marudanayagam, Ravi
    Mirza, Darius
    Roberts, Keith
    Sutcliffe, Robert
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [37] Multimodality Management of Ampullary Carcinoma: Analysis from the Ampullary Carcinoma Study Group
    Ecker, Brett L.
    Vollmer, Charles M., Jr.
    Behrman, Stephen W.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S175 - S175
  • [38] Outcomes following pancreaticoduodenectomy for octogenarians: a systematic review and meta-analysis
    Phillipos, Joseph
    Lim, Kai-Zheong
    Pham, Helen
    Johari, Yazmin
    Pilgrim, Charles H. C.
    Smith, Marty
    HPB, 2024, 26 (12) : 1435 - 1447
  • [39] Predictors of Survival in Ampullary, Bile Duct and Duodenal Cancers Following Pancreaticoduodenectomy: a 10-Year Multicentre Analysis
    Bourgouin, Stephane
    Ewald, Jacques
    Mancini, Julien
    Moutardier, Vincent
    Delpero, Jean-Robert
    Le Treut, Yves-Patrice
    JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (07) : 1247 - 1255
  • [40] Treatment Patterns and Outcomes for Patients with Ampullary Carcinoma Who Do Not Undergo Surgery
    Facer, Benjin D.
    Cloyd, Jordan M.
    Manne, Ashish
    Pitter, Kenneth L.
    Diaz, Dayssy A.
    Bazan, Jose G.
    Miller, Eric D.
    CANCERS, 2023, 15 (14)